DESTINA Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$250K
- Investors
-
5
DESTINA General Information
Description
Developer of molecular diagnostic products designed to detect nucleic acids and single nucleotide polymorphisms (SNPs). The company's product and services are based on a molecular diagnostic that focuses on the development of simpler, accurate, and cost-effective products for PCR-free detection of microRNAs, enabling healthcare providers to treat toxicology, illness, and diseases of patients.
Contact Information
Website
www.destinagenomics.comCorporate Office
- Avenida de la Innovación, 1
- Los Vergeles
- 18100 Granada
- Spain
Corporate Office
- Avenida de la Innovación, 1
- Los Vergeles
- 18100 Granada
- Spain
DESTINA Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Later Stage VC | 22-May-2017 | $250K | Completed | Product In Beta Test | ||
8. Later Stage VC | 02-Oct-2014 | Completed | Product In Beta Test | |||
7. Grant | 01-Nov-2012 | Completed | Startup | |||
6. Early Stage VC | 01-Sep-2012 | Completed | Startup | |||
5. Seed Round | 04-Mar-2011 | Completed | Startup | |||
4. Grant | 01-Jan-2011 | Completed | Startup | |||
3. Seed Round | 17-Dec-2010 | Completed | Startup | |||
2. Accelerator/Incubator | Completed | Startup | ||||
1. Seed Round | 01-Jan-2008 | Completed | Startup |
DESTINA Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary 2 | ||||||||
Ordinary 1 |
DESTINA Comparisons
Industry
Financing
Details
DESTINA Competitors (18)
One of DESTINA’s 18 competitors is Voyager Therapeutics, a Corporation company based in Cambridge, MA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Voyager Therapeutics | Corporation | Cambridge, MA | ||||
Intellia Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
Wayfinder Biosciences | Venture Capital-Backed | Seattle, WA | ||||
Tiba Biotech | Venture Capital-Backed | Cambridge, MA | ||||
Gradalis | Private Equity-Backed | Carrollton, TX |
DESTINA Patents
DESTINA Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20200123592-A1 | Single molecule detection and quantification of nucleic acids with single base specificity | Inactive | 30-May-2017 | ||
GB-201616556-D0 | Improved pna probe | Inactive | 12-Jul-2016 | ||
US-11242526-B2 | Pna probe | Active | 12-Jul-2016 | ||
US-20190233818-A1 | Improved pna probe | Active | 12-Jul-2016 | ||
EP-3485014-A1 | Pna probe | Active | 12-Jul-2016 | C12Q1/6876 |
DESTINA Signals
DESTINA Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Old College Capital | Corporate Venture Capital | Minority | ||
Vitro | PE-Backed Company | Minority | ||
University of Edinburgh Endowment | Limited Partner | Minority | ||
Scottish Enterprise | Government | Minority | ||
SantanderX | Accelerator/Incubator |
DESTINA FAQs
-
When was DESTINA founded?
DESTINA was founded in 2008.
-
Where is DESTINA headquartered?
DESTINA is headquartered in Granada, Spain.
-
What is the size of DESTINA?
DESTINA has 4 total employees.
-
What industry is DESTINA in?
DESTINA’s primary industry is Biotechnology.
-
Is DESTINA a private or public company?
DESTINA is a Private company.
-
What is DESTINA’s current revenue?
The current revenue for DESTINA is
. -
How much funding has DESTINA raised over time?
DESTINA has raised $2.44M.
-
Who are DESTINA’s investors?
Old College Capital, Vitro, University of Edinburgh Endowment, Scottish Enterprise, and SantanderX have invested in DESTINA.
-
Who are DESTINA’s competitors?
Voyager Therapeutics, Intellia Therapeutics, Wayfinder Biosciences, Tiba Biotech, and Gradalis are some of the 18 competitors of DESTINA.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »